MedTrace Logo

Efficacy and Safety of Carboxymethyl Beta-glucan and Policarbophil in HPV Positive Patients

NCT06199128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 533

Last updated 2024-01-10

No results posted yet for this study

Summary

Prospective, Controlled, Multicentre, Real Clinical Practice Study. Effectiveness of Carboxymethyl β-Glucan treatment in high-risk HPV+ patients

Conditions

  • Human Papillomavirus Infection

Interventions

DIETARY_SUPPLEMENT

carboxymethyl β-glucan

It is a vaginal spray gel designed for the prevention and treatment of cervical lesions caused by HPV. This is achieved by controlling the physiological conditions of the transformation zone of the cervico-vaginal mucosa. The composition of the gel, which includes polycarbophil and carboxymethyl-beta-glucan, effectively shields the cervico-vaginal mucosa from the damaging effects of external agents due to its bioadhesive capacity. Additionally, it contributes to the re-epithelialization and regression of cervical lesions

Sponsors & Collaborators

  • Uriach Consumer Healthcare

    lead INDUSTRY

Principal Investigators

  • Carmen Pingarrón Santofima, Doctor · Hospital Quirón San José

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-22
Primary Completion
2023-09-22
Completion
2023-11-22

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06199128 on ClinicalTrials.gov